PAR HEALTH
LIVE

Serial Number

99409684

Owner

PH HEALTH LIMITED

Attorney

Camille M. Miller

Filing Date

Sep 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PAR HEALTH Trademark

Serial Number: 99409684

PAR HEALTH is a trademark filed by PH HEALTH LIMITED on September 24, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

PH HEALTH LIMITED (72 trademarks)

FIRST FLOOR MINERVA HOUSE
BALLSBRIDGE, DUBLIN 4 D04 H9P8 , IE

Entity Type: 99

Trademark Details

Filing Date

September 24, 2025

Registration Date

Not Registered

Published for Opposition

March 10, 2026

Goods & Services

Pharmaceutical products for the treatment of pain management, infectious diseases, central nervous system disorders, namely epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; Pharmaceutical preparations for the treatment of pain management, infectious diseases, central nervous system disorders, namely epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; ready-to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities; radio frequency identification tagged pharmaceutical products, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, diuretic agents, psychiatrics, antivirals, thyroid agents, corticosteroids, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents

Outsourcing services in the nature of arranging procurement of goods for others in the field of pharmaceuticals; Business administration of patient reimbursement programs for pharmaceuticals; Business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient

Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services

Charitable Services, namely patient assistance programs that provide pharmaceuticals to help patients with low income get pharmaceuticals at little or no cost to the patient

Custom manufacture of pharmaceutical products to the order and specification of others; Providing technical information in the field of pharmaceutical manufacturing

Filing History

TEAS STATEMENT OF USE RECEIVED
Jun 26, 2026 EISU
TEAS STATEMENT OF USE RECEIVED
May 6, 2026 EISU
TEAS REQUEST TO DIVIDE RECEIVED
May 6, 2026 ERTD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 17, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 17, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 17, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 17, 2026 CNEA
ASSIGNED TO EXAMINER
Feb 17, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 24, 2025 MAFR
NEW APPLICATION ENTERED
Sep 24, 2025 NWAP